Please login to the form below

Not currently logged in
Email:
Password:

research spend

This page shows the latest research spend news and features for those working in and with pharma, biotech and healthcare.

German pharma market to edge up to $65bn by 2020

German pharma market to edge up to $65bn by 2020

Germany's pharmaceutical market will only 'crawl' forward for the rest of the decade as the country looks to reduce spend on new medicines, according to research and consulting firm GlobalData.

Latest news

  • Selfie campaign boosts cancer funds Selfie campaign boosts cancer funds

    Without it we wouldn't have received over £140, 000 to spend on life-saving research.”. ... Cancer Research UK said it had had more than 800, 000 text donations in the latter half of last week, raising close to £1.5m.

  • Pharma's return on R&D spend continues to slide Pharma's return on R&D spend continues to slide

    Pharma's return on R&D spend continues to slide. And cost of launching new medicine rises to $1.3bn says report. ... statement, adding that while R&D spend has increased in absolute terms, efforts to improve efficiencies have yet to kick in.

  • European R&D investment European R&D investment "stagnating"

    European R&D investment "stagnating". Report says health research spend was flat in 2011. ... Commenting on the new report, Jane Griffiths - who is the chair of Janssen's EMEA business - noted that the downturn in R&D spend is a worrying signal in light

  • Patient-centricity for pharma marketers Patient-centricity for pharma marketers

    It's difficult to empathise. Marketers must spend time in immersive research, ie, in the day to day lives of patients. ... 5.Be better than before. How much research is done to improve patients' experience of existing products?

  • European pharma patent court deal sealed European pharma patent court deal sealed

    The agreement will help our inventors who can in future spend more time on research and development, producing new ideas and less time filling in forms and defending their patents in

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    The diabetic population shows no sign of reducing any time soon, with research suggesting that the number of diabetics in Europe is expected to grow from 58 million today to 67 ... biosimilar and the promise of Mylan’s pipeline, which is fuelled by an

  • Turkey's pharma market is ripe for profitability Turkey's pharma market is ripe for profitability

    During profitable years, Turkish pharmaceutical manufacturers were earning so much money from selling generics that they didn't spend time on research.”. ... Kemal Yildiz, Berko Pharmaceuticals argues that this has influenced Turkish pharmaceutical

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Optimising Research in Healthcare

    Optimising Research in Healthcare. Medical device manufacturers spend millions of pounds on NPD so how can they ensure that their products end up in the right hands? ... This 25 minute Sky broadcast featuring CMR explains how innovative human factors

  • How Transparent Is Transparency?

    What disclosure hasn’ t taught us, or made any effort to promote, is just how much money pharmaceutical companies spend in bringing a product to market; the years of research and ... 190m of that spend was in research and development contracts and 207m

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics